CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors
Authors
AA Gabizon
AL Green
+56 more
AS Azmi
AS Azmi
Daniel M. Sullivan
F Barcelo
G Pathria
GI Giles
GL Gravina
H Inoue
H Sun
HI Wettersten
J Etchin
J Gao
J Schmidt
Jana L. Dawson
JG Turner
JG Turner
JG Turner
JG Turner
JG Turner
Joel G. Turner
K Zhang
Kenneth H. Shain
KM Tewey
M De Cesare
Mark Meads
Michael Kauffman
NI Valkov
O Soderberg
P Ranganathan
PL Olive
PL Olive
PL Olive
R Engel
R Lapalombella
RA Salas Fragomeni
Rachid Baz
RC Baz
RC Baz
RZ Orlowski
S Chen
S Chen
Sharon Shacham
Steven Grant
T Miyake
V Marx
William S. Dalton
WS Dalton
WS Dalton
WT Bellamy
XY Pei
Y Cheng
Y Tabe
Y Zheng
YT Tai
Yun Dai
ZA Hing
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs13045-016-...
Last time updated on 05/06/2019